December 2, 2014

Ranbaxy Laboratories on Monday announced the launch of Infimab (BOW015), the first Remicade (Infliximab) biosimilar in India. The product was launched at the Indian Rheumatology Association Conference in Chandigarh.

December 2, 2014

Teva Pharmaceuticals on Monday announced the introduction and availability of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate Sublingual Tablets, CIII.

December 2, 2014

Walgreens introduced its new Flu Index.

 

December 1, 2014

November front-end drug store sales are expected to be comparable to last year while prescriptions dispensed will be up in the low single-digit range, reported Ed Kelly, Credit Suisse research analyst.

 

December 1, 2014

The Food and Drug Administration recently issued draft guidance on key product tracing provisions of the Drug Supply Chain Security Act, which is expected to be implemented by the industry on Jan. 1, 2015. 

December 1, 2014

Drug Store News will be tweeting key messages from retail pharmacy industry heavyweights.

December 1, 2014

NACDS advocated for the voluntary ability of pharmacies to extend their reward and loyalty programs to beneficiaries in government programs.

December 1, 2014

Teva Pharmaceutical on Monday announced the launch of a generic version of Exforge HCT (amlodipine, valsartan, hydrochlorothiazide) tablets in the United States. 

November 26, 2014

The American College of Emergency Physicians on Tuesday warned against overindulgence through the holidays in an effort to raise awareness around diabetes. 

November 26, 2014

Just 30% of Americans with HIV had the virus under control in 2011, and approximately two-thirds of those whose virus was out of control had been diagnosed but were no longer in care.

November 25, 2014

The Council for Responsible Nutrition on Monday announced the next in its series of free webinars for pharmacists and nurse practitioners, presented in partnership with Skipta.

 

November 25, 2014

Recently, NACDS provided a summary of the 2014 midterm elections, with an emphasis on the federal level. This memo includes an overview of the state elections, which will shape the operating environment on pivotal state issues.

November 25, 2014

Mylan on Tuesday confirmed that it — along with several subsidiaries — has been sued by Baxter International, Baxter Healthcare Corp. and Baxter Healthcare S.A. in relation to the filing of an abbreviated new drug application for the generic version of Brevibloc. 

November 25, 2014

Walgreens on Tuesday announced that its special shareholders' meeting to decide the acquisition of the rest of Alliance Boots is set for Dec. 29 in New York.

November 24, 2014

American Well is among the first healthcare providers to see an uptick in online visits associated with influenza-like symptoms.

November 24, 2014

Dr. Reddy's Labs on Monday announced the launch of docetaxel injection USP in 20-mg and 80-mg dosage strengths. The drug is the generic version of Taxotere.

 

November 24, 2014

Endo on Monday announced the acquisition of rights to Natesto (testosterone nasal gel), a testosterone nasal gel for replacement therapy in adult males diagnosed with hypogonadism. 

November 24, 2014

Omnicare and McKesson on Monday announced the signing of an expanded agreement to include the sourcing and distribution of branded, specialty and generic pharmaceuticals. 

November 24, 2014

Perrigo on Monday announced that it has agreed to market the authorized generic version of Astellas U.S.' Protopic ointment 0.1% and 0.03%. 

November 24, 2014

VOA Associates on Monday announced the opening of a new Walgreens Health System Pharmacy at Northwestern Memorial Hospital’s Galter Pavilion.

November 21, 2014

The membership of the Pharmacy Quality Alliance has endorsed a new performance measure, Statin Use in Persons with Diabetes, the group announced Friday. 

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

Amneal Pharmaceuticals on Thursday announced the launch of Lopreeza (estradiol/norethindrone acetate) tablets in 0.5-mg and 1-mg dosage strengths. The product is the first authorized generic of Activella from Novo Nordisk.

 

November 20, 2014

Walgreens may be in a year of transition through 2015.